Revolutionising cellular therapies for cancer and beyond

We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

Cartherics comes together to raise awareness and shine a spotlight on ovarian cancer

By Christine Filippis / February 27, 2025
As Ovarian Cancer Awareness Month draws to a close, the Cartherics team gathered for an afternoon dedicated to raising awareness...
Read More

iPSC-Derived NK Cells and the Future of Immunotherapy

By Christine Filippis / February 14, 2025
Induced pluripotent stem cell (iPSC)-derived NK cells are revolutionising cancer immunotherapy by offering a scalable and reliable source of immune...
Read More

Cartherics presents at Australia and New Zealand’s Biologics Festival

By Christine Filippis / February 7, 2025
Cartherics’ Chief Operating Officer, Dr. Ian Nisbet recently presented at the 3rd ANZ Biologics Festival at Crown Promenade in Melbourne....
Read More